Glenmark Pharma transfers API business to Glenmark Life Sciences

02 Jan 2019 Evaluate

Glenmark Pharmaceuticals has transferred its Active Pharmaceuticals Ingredient (API) business to Glenmark Life Sciences, a wholly owned subsidiary of the company. This transfer was completed on December 31, 2018.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

426.60 6.85 (1.63%)
25-Nov-2022 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1033.30
Cipla 1105.15
Dr. Reddys Lab 4418.00
Lupin 719.45
Zydus Lifesciences 401.80
View more..